Warthausen, Germany

Stephan Kling



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovative Contributions of Stephan Kling

Introduction

Stephan Kling, an accomplished inventor based in Warthausen, Germany, has made significant strides in the field of pharmaceuticals. With a total of two patents to his name, Kling is dedicated to innovating processes that have substantial implications in medical treatments. His expertise in stereoselective synthesis has garnered attention in the pharmaceutical industry.

Latest Patents

Among his notable inventions is the patent for the "Stereoselective Synthesis of Bicyclic Heterocycles." This innovative process focuses on the stereoselective preparation of compounds designated by formulae (1A) and (1B), including their physiologically acceptable salts. These compounds exhibit valuable pharmacological properties, especially in inhibiting signal transduction mediated by tyrosine kinases. The utility of these inventions extends to treating various diseases, including tumoral diseases and benign prostatic hyperplasia (BPH), as well as conditions affecting the lungs and airways. His work marks a significant contribution to therapeutic developments in modern medicine.

Career Highlights

Stephan Kling is associated with Boehringer Ingelheim International GmbH, a renowned global company in the pharmaceutical sector. His tenure at this organization has positioned him as a key player in the innovation of medicinal chemistry, specifically in creating effective treatments for pressing healthcare issues.

Collaborations

Throughout his career, Kling has collaborated with esteemed colleagues such as Markus Ostermeier and Juergen Daeubler. These partnerships are testament to the teamwork and synergy that drive advancements in research and development within the pharmaceutical industry.

Conclusion

In conclusion, Stephan Kling's contributions to the field of pharmaceuticals through his innovative patents are noteworthy. His dedication to the stereoselective synthesis of compounds reveals his commitment to enhancing medical treatment options. With a strong collaborative spirit and a focus on impactful research, Kling continues to be a significant figure in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…